Cheno- plus Ursodeoxycholic Acid

  • M. Podda
  • M. Zuin
  • P. M. Battezzati


Oral therapy for gallstones has, some say, induced more disillution than dissolution1,2; others are less pessimistic3. Few patients with gallstones fulfill the criteria for successful treatment4 and many are disappointed by the limited efficacy of dissolution therapy, or discouraged by its adverse effects, duration and cost.


Bile Acid Ursodeoxycholic Acid Chenodeoxycholic Acid Cholesterol Gallstone Bile Acid Synthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dissolving hopes for gallstone dissolution (Editorial ) (1981). Lancet, 2, 905–6Google Scholar
  2. 2.
    Isselbacher, K J. (1981). Chenodiol for gallstones: dissolution or disillusion? (Editorial) Ann. Intern. Med., 95, 377–9PubMedGoogle Scholar
  3. 3.
    Palmer, R.H. and Carey, M.C. (1982). An optimistic view of the National Cooperative Gallstone Study. N. Engl J. Med., 306, 1171–4PubMedCrossRefGoogle Scholar
  4. 4.
    Northfield, T.C. and Maudgal, D.P. (1986). Oral medical therapy. In: Bateson, M.C. (ed.), Gallstone Disease and its Management, pp. 203–27. (Lancaster: MTP Press)Google Scholar
  5. 5.
    Barbara, L., Sama, C., Morselli Labate A.M. et al. (1987). A Population study on the prevalence of gallstone disease: the Sirmione study. Hepatology, 7, 913–7PubMedCrossRefGoogle Scholar
  6. 6.
    Fromm, H. (1986). Gallstone dissolution therapy. Current status and future prospects. Gastroenterology, 91, 1560–7PubMedGoogle Scholar
  7. 7.
    Fromm, H. (1984). Gallstone dissolution and the cholesterol-bile acid-lipoprotein axis. Propitious effect of ursodeoxycholic acid. Gastroenterology, 87, 229–33PubMedGoogle Scholar
  8. 8.
    Tint, G.S., Salen, G. and Shefer, S. (1986). Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterology, 90, 1007–18Google Scholar
  9. 9.
    Salvioli, G., Igimi, H. and Carey, M.C. (1983). Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanism. J. Lipid Res., 24, 701–20PubMedGoogle Scholar
  10. 10.
    Corrigan, O.I., Su, C.C., Higuchi, W.I. and Hofmann, A.F. (1980). Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans. J. Pharm. Sci., 69, 869–71PubMedCrossRefGoogle Scholar
  11. 11.
    von Bergmann, K., Epple-Gutsfeld, M. and Leiss, O. (1984). Differences in the effects of chenodeoxycholic and ursodeoxycholic acids in biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology, 87, 136–43Google Scholar
  12. 12.
    Nilsell, K., Angelin, B., Leijd, B. and Einarsson, K. (1983). Comparative effect of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in man. Evidence for different modes of action on bile acid synthesis. Gastroenterology, 85, 1248–56PubMedGoogle Scholar
  13. 13.
    Mok, H.Y.I., Bell, G.D. and Dowling, R.H. (1974). Effect of different doses of chenodeoxycholic acid on bile lipid composition and on frequency of side effects in patients with gallstones. Lancet, 2, 253–7PubMedCrossRefGoogle Scholar
  14. 14.
    Thistle, J.L., Hofmann, A.F., Ott, B J. and Stephens, D.H. (1978). Chenotherapy for gallstone dissolution: I. Efficacy and safety. J. Am. Med. Assoc., 239, 1041–6CrossRefGoogle Scholar
  15. 15.
    Miyai, K., Toyota, N., Jones, H.M. and Gochman, N. (1982). Protective effect of ursodeoxycholic acid against cholestatic and hepatotoxic effects of lithocholic acid (Abstr.). Hepatology, 2, 705Google Scholar
  16. 16.
    Krol, T., Kitamura, T., Miyai, K. and Hardison, W. (1983). Tauroursodeoxycholate reduces dictular proliferation in bile duct-ligated hamsters (Abstr.). Hepatology, 3, 881Google Scholar
  17. 17.
    Tanikawa, K., Kawahara, T., Kumashiro, R. et al. (1986). Effects of bile acids on the cultured hepatocyte and Kupffer cell (Abstr). Hepatology, 6, 779Google Scholar
  18. 18.
    Poupon, R., Chretien, Y., Poupon, R.E. et al. (1987). Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?Lancet, 1, 834–6PubMedCrossRefGoogle Scholar
  19. 19.
    Podda, M., Zuin, M., Dioguardi, M.L., Festorazzi, S. and Dioguardi, N. (1982). A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation. Hepatology, 2, 334–9PubMedCrossRefGoogle Scholar
  20. 20.
    Stiehl, A., Raedsch, R., Czygan, P., Gotz, R., Manner, C.H. and Walker, S. (1980). Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid. Gastoenterology, 79, 1192–8Google Scholar
  21. 21.
    Carey, M.C. and Ko, G. (1979). The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating ’percent cholesterol saturation’ with a correction factor for ursodeoxycholic-rich bile. In: Paumgartner, G., Stiehl, A. and Gerok, W. (eds.), Biological Effects of Bile Acids, pp. 299–308. (Lancaster: MTP Press).Google Scholar
  22. 22.
    Roehrkasse, R., Fromm, H., Malavolti, M., Tunuguntla, A.K. and Ceryak, S. (1986). Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool and serum lipids. Dig. Dis. Sci, 31, 1032–40PubMedCrossRefGoogle Scholar
  23. 23.
    Thistle, J.L. (1987). Dissolution of gallstones using ursodeoxycholic acid with or without chenodeoxycholic acid or taurine. In: Paumgartner, G., Stiehl, A. and Gerok, W. (eds.), Biological Effects of Bile Acids, pp. 353–4. (Lancaster: MTP Press).Google Scholar
  24. 24.
    Czygan, P (1987). Efficacy of combined ursodeoxycholic and chenodeoxycholic acid treatment. In: Paumgartner, G., Stiehl, A. and Gerok, W. (eds.), Biological Effects of Bile Acids, pp. 343–4. (Lancaster: MTP Press).Google Scholar
  25. 25.
    Kawamoto, T., Horiuchi, I., Hino, F., Okahashi, M. and Kajiyama, G. (1984). Combination treatment with different doses of urso (U) and chenodeoxycholic acid (C) in patients with cholesterol gallstones (Abstr) In: Proceedings of the VIII International Bile Acid Meeting Berne, p. 183Google Scholar
  26. 26.
    Bateson, M.C., Bouchier, I.A.D., Trash, D.B., Maudgal, D.P. and Northfield, T.C. (1981). Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid. Br. Med. J., 283, 645–6CrossRefGoogle Scholar
  27. 27.
    Roda, E., Bazzoli, F., Labate, W.M.N, et al. (1982). Ursodeoxycholic acid vs chenodeoxycholic acid as cholesterol gallstone dissolving agents: a comparative study. Hepatology, 2, 804–10PubMedCrossRefGoogle Scholar
  28. 28.
    Fromm, H., Roat, J.N., Gonzales, V., Sarva, R.J. and Farivar, S. (1983). Comparative efficacy and side effects of ursodeoxycholic acid and chenodeoxycholic acid in dissolving gallstones. Gastoenterology, 85, 1257–64Google Scholar
  29. 29.
    Sauerbruch, T., Delius, M., Paumgartner, G et al. (1986). Fragmentation of gallstone by extracorporeal shock waves. N. Engl. J. Med., 314, 818–22PubMedCrossRefGoogle Scholar
  30. 30.
    Igimi, H. and Carey, M.C. (1980). pH-solubility relation of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar dissolution and membrane phenomena. J. Lipid Res., 21, 72–89Google Scholar
  31. 31.
    Schoenfield, L.J. and Lachin, J.M. (1981). The Steering Committee and the National Cooperative Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study .Ann. Intern. Med., 95, 257–82PubMedGoogle Scholar
  32. 32.
    Toulet, J., Rousselet, J., Viteau, J.M. et al. (1983). Dissolutions incomplete des calculs. Calcification, cholecystectomies après traitaient de la lithiase vesiculate par l’acide chenodesoxycholique. Gastroenterol, Clin. Biol, 7, 969–74PubMedGoogle Scholar
  33. 33.
    Hofmann, A.F. and Cummings, S.A. (1985). Biliary calcium secretion and its relationship to biliary calcium concentration and biliary calcium activity. In: Barbara, L., Dowling, P.H., Hofmann, A.F. and Roda, E. (eds.), Recent Advances in Bile Acid Research, pp. 87–108. (New York: Raven Press)Google Scholar
  34. 34.
    Bachrach, W.H. and Hofmann, A.F. (1982). Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig. Dis. Sci, 27, 833–55PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • M. Podda
    • 1
  • M. Zuin
    • 1
  • P. M. Battezzati
    • 1
  1. 1.Istituto di Medicina InternaMilan UniversityMilanItaly

Personalised recommendations